-
公开(公告)号：US20090254135A1
公开(公告)日：2009-10-08
申请号：US12419074
申请日：2009-04-06
CPC分类号： A61N1/3621 , A61N1/3906
摘要： Embodiments of the invention are related to medical devices and methods for delivery high-energy anti-tachycardia therapy to a subject, amongst other things. In an embodiment, the invention includes a medical device including a controller module configured to administer a plurality of electrical pulses to a patient in response to a detected tachycardia, the electrical pulses comprising an amplitude of greater than 3 Volts and less than 40 Volts, the controller configured to modulate the amplitude of the electrical pulses. In an embodiment, the invention includes a method of treating a tachyarrhythmia including administering a first series of electrical pulses to a patient with an implantable medical device, the electrical pulses including an amplitude of greater than 8 Volts and less than 40 Volts, the first series of electrical pulses having an interval of less than about 600 ms in between individual pulses. Other embodiments are also included herein.
摘要翻译： 本发明的实施例涉及用于向对象递送高能抗心动过速疗法的医疗装置和方法。 在一个实施例中，本发明包括医疗装置，其包括控制器模块，其被配置为响应于检测到的心动过速向患者施加多个电脉冲，所述电脉冲包括大于3伏且小于40伏的振幅， 控制器被配置为调制电脉冲的幅度。 在一个实施方案中，本发明包括治疗快速性心律失常的方法，包括用可植入医疗装置向患者施用第一系列电脉冲，所述电脉冲包括大于8伏且小于40伏特的振幅，第一系列 在各个脉冲之间具有小于约600ms的间隔的电脉冲。 本文还包括其它实施例。
-
公开(公告)号：US08412325B2
公开(公告)日：2013-04-02
申请号：US12419074
申请日：2009-04-06
IPC分类号： A61N1/362
CPC分类号： A61N1/3621 , A61N1/3906
摘要： Embodiments of the invention are related to medical devices and methods for delivery high-energy anti-tachycardia therapy to a subject, amongst other things. In an embodiment, the invention includes a medical device including a controller module configured to administer a plurality of electrical pulses to a patient in response to a detected tachycardia, the electrical pulses comprising an amplitude of greater than 3 Volts and less than 40 Volts, the controller configured to modulate the amplitude of the electrical pulses. In an embodiment, the invention includes a method of treating a tachyarrhythmia including administering a first series of electrical pulses to a patient with an implantable medical device, the electrical pulses including an amplitude of greater than 8 Volts and less than 40 Volts, the first series of electrical pulses having an interval of less than about 600 ms in between individual pulses. Other embodiments are also included herein.
摘要翻译： 本发明的实施例涉及用于向对象递送高能抗心动过速疗法的医疗装置和方法。 在一个实施例中，本发明包括医疗装置，其包括控制器模块，其被配置为响应于检测到的心动过速向患者施加多个电脉冲，所述电脉冲包括大于3伏且小于40伏的振幅， 控制器被配置为调制电脉冲的幅度。 在一个实施方案中，本发明包括治疗快速性心律失常的方法，包括用可植入医疗装置向患者施用第一系列电脉冲，所述电脉冲包括大于8伏且小于40伏特的振幅，第一系列 在各个脉冲之间具有小于约600ms的间隔的电脉冲。 本文还包括其它实施例。
-
3.发明申请公开(公告)号：US20080275520A1
公开(公告)日：2008-11-06
申请号：US11799794
申请日：2007-05-03
申请人： Donald L. Hopper , Yinghong Yu , Allan Charles Shuros , Shantha Arcot-Krishnamurthy , Gerrard M. Carlson , Jeffrey Stahmann
发明人： Donald L. Hopper , Yinghong Yu , Allan Charles Shuros , Shantha Arcot-Krishnamurthy , Gerrard M. Carlson , Jeffrey Stahmann
IPC分类号： A61N1/365
CPC分类号： A61N1/36585 , A61N1/368 , A61N1/3682 , A61N1/3684
摘要： Methods and systems to modulate timing intervals for pacing therapy are described. For each cardiac cycle, one or both of an atrioventricular (A-V) timing interval and an atrial (A-A) timing interval are modulated to oppose beat-to-beat ventricular (V-V) timing variability. Pacing therapy is delivered using the modulated timing intervals.
摘要翻译： 描述了调节起搏治疗时间间隔的方法和系统。 对于每个心动周期，房室（A-V）定时间隔和心房（A-A）定时间隔中的一个或两个被调制以抵抗搏动到心室（V-V）的时间变异性。 使用调制的定时间隔来提供起搏治疗。
-
4.发明授权公开(公告)号：US08103343B2
公开(公告)日：2012-01-24
申请号：US11799794
申请日：2007-05-03
申请人： Donald L. Hopper , Yinghong Yu , Allan Charles Shuros , Shantha Arcot-Krishnamurthy , Gerrard M. Carlson , Jeffrey Stahmann
发明人： Donald L. Hopper , Yinghong Yu , Allan Charles Shuros , Shantha Arcot-Krishnamurthy , Gerrard M. Carlson , Jeffrey Stahmann
IPC分类号： A61N1/362
CPC分类号： A61N1/36585 , A61N1/368 , A61N1/3682 , A61N1/3684
摘要： Methods and systems to modulate timing intervals for pacing therapy are described. For each cardiac cycle, one or both of an atrioventricular (A-V) timing interval and an atrial (A-A) timing interval are modulated to oppose beat-to-beat ventricular (V-V) timing variability. Pacing therapy is delivered using the modulated timing intervals.
摘要翻译： 描述了调节起搏治疗时间间隔的方法和系统。 对于每个心动周期，房室（A-V）定时间隔和心房（A-A）定时间隔中的一个或两个被调制以抵抗搏动到心室（V-V）的时间变异性。 使用调制的定时间隔来提供起搏治疗。
-
5.发明授权Temperature based systems and methods for tachycardia discrimination and therapy 有权用于心动过速鉴别和治疗的基于温度的系统和方法公开(公告)号：US08255052B2
公开(公告)日：2012-08-28
申请号：US12411157
申请日：2009-03-25
申请人： Rodney W. Salo , Allan Charles Shuros , Dan Li
发明人： Rodney W. Salo , Allan Charles Shuros , Dan Li
IPC分类号： A61N1/36
CPC分类号： A61N1/3622 , A61N1/3962
摘要： Embodiments of the invention are related to an implantable medical system, amongst other things. In an embodiment, the invention includes a processor, an electrical sensor, and a temperature sensor. The processor is configured to monitor myocardial electrical activity with input from the electrical sensor; identify myocardial electrical activity indicative of an arrhythmia, measure temperature of blood in the coronary venous system with input from the temperature sensor; determine if the arrhythmia is hemodynamically stable or hemodynamically unstable based on the temperature of blood in the coronary venous system, and initiate high-voltage shock therapy if the arrhythmia is hemodynamically unstable. Other embodiments are also included herein.
摘要翻译： 本发明的实施例涉及可植入医疗系统等。 在一个实施例中，本发明包括处理器，电传感器和温度传感器。 处理器被配置为通过来自电传感器的输入来监测心肌电活动; 识别指示心律失常的心肌电活动，用来自温度传感器的输入测量冠状静脉系统中血液的温度; 根据冠状静脉系统中的血液温度，确定心律失常是否为血液动力学稳定或血液动力学不稳定，如果心律失常是血液动力学不稳定的话，开始进行高压休克治疗。 本文还包括其它实施例。
-
6.发明申请Temperature Based Systems and Methods for Tachycardia Discrimination and Therapy 有权基于温度的系统和方法用于心动过速鉴别和治疗公开(公告)号：US20090254137A1
公开(公告)日：2009-10-08
申请号：US12411157
申请日：2009-03-25
申请人： Rodney W. Salo , Allan Charles Shuros , Dan Li
发明人： Rodney W. Salo , Allan Charles Shuros , Dan Li
IPC分类号： A61N1/05
CPC分类号： A61N1/3622 , A61N1/3962
摘要： Embodiments of the invention are related to an implantable medical system, amongst other things. In an embodiment, the invention includes a processor, an electrical sensor, and a temperature sensor. The processor is configured to monitor myocardial electrical activity with input from the electrical sensor; identify myocardial electrical activity indicative of an arrhythmia, measure temperature of blood in the coronary venous system with input from the temperature sensor; determine if the arrhythmia is hemodynamically stable or hemodynamically unstable based on the temperature of blood in the coronary venous system, and initiate high-voltage shock therapy if the arrhythmia is hemodynamically unstable. Other embodiments are also included herein.
摘要翻译： 本发明的实施例涉及可植入医疗系统等。 在一个实施例中，本发明包括处理器，电传感器和温度传感器。 处理器被配置为通过来自电传感器的输入来监测心肌电活动; 识别指示心律失常的心肌电活动，用来自温度传感器的输入测量冠状静脉系统中血液的温度; 根据冠状静脉系统中的血液温度，确定心律失常是否为血液动力学稳定或血液动力学不稳定，如果心律失常是血液动力学不稳定的话，开始进行高压休克治疗。 本文还包括其它实施例。
-
公开(公告)号：US08475400B2
公开(公告)日：2013-07-02
申请号：US13346485
申请日：2012-01-09
CPC分类号： A61B17/1219 , A61B17/12031 , A61B17/12036 , A61B17/12099 , A61B17/12136 , A61F2250/0003
摘要： Embodiments of the invention are related to devices and methods for modulating renal function, amongst other things. In an embodiment, the invention includes a method of modulating renal function in a patient including implanting an occlusive device in the patient, the occlusive device comprising a semi-permeable membrane and configured to expand or contract based on the passage of a fluid across the semi-permeable membrane. Other aspects and embodiments are provided herein.
摘要翻译： 本发明的实施方案涉及用于调节肾功能的装置和方法等。 在一个实施方案中，本发明包括调节患者的肾功能的方法，包括在患者体内植入闭塞装置，所述闭塞装置包括半渗透膜，并且构造成基于穿过所述半透膜的流体通过而膨胀或收缩 不渗透膜。 本文提供了其它方面和实施例。
-
公开(公告)号：US07734349B2
公开(公告)日：2010-06-08
申请号：US11779403
申请日：2007-07-18
IPC分类号： A61B5/14
CPC分类号： A61N1/3702 , A61B5/0006 , A61B5/02028 , A61B5/076 , A61B5/14539 , A61B5/14546 , A61B5/4869 , A61B2562/02 , A61N1/05 , A61N1/36521 , A61N1/36557 , G01N13/04
摘要： Embodiments of the invention are related to monitoring devices and methods with osmometric sensors, amongst other things. In an embodiment, the invention includes an implantable heart failure monitoring system including an osmometric sensor, the osmometric sensor configured to generate a signal corresponding to the osmotic strength of a bodily fluid, and a controller in communication with the osmometric sensor, the controller configured to receive and process the signal corresponding to the osmotic strength of a bodily fluid. Other aspects and embodiments are provided herein.
摘要翻译： 本发明的实施例涉及到具有渗压传感器的监测装置和方法以及其它方面。 在一个实施例中，本发明包括可植入心力衰竭监测系统，其包括渗透传感器，所述渗透传感器被配置为产生对应于体液的渗透强度的信号，以及与所述渗透传感器通信的控制器，所述控制器被配置为 接收和处理对应于体液渗透强度的信号。 本文提供了其它方面和实施例。
-
公开(公告)号：US20090088651A1
公开(公告)日：2009-04-02
申请号：US11904946
申请日：2007-09-28
IPC分类号： A61B5/0215
CPC分类号： A61B5/0215 , A61B5/02028 , A61B5/418 , A61N1/36514
摘要： An implantable transvascular pressure sensing device may include at least one deflection sensor configured to output a deflection signal indicative of vascular wall deflections. A implantable transvascular pressure sensing device may further include an implantable sensor support member attached to the deflection sensor, the sensor support member configured to facilitate contact between the deflection sensor and a first vessel wall at a portion of a first vessel proximate a second vessel, wherein the portion of the first vessel wall is adjacent to the second vessel such that wall deflections of the second vessel deflect the portion of the first vessel wall. A method of measuring a parameter of a vessel can include generating a deflection signal from a sensor within a vein, the deflection signal indicative of venous wall deflections of the vein, and determining a parameter value associated with a vessel contacting the vein using the deflection signal.
摘要翻译： 可植入的经血管压力感测装置可以包括被配置为输出指示血管壁偏转的偏转信号的至少一个偏转传感器。 可植入的经血管压力感测装置还可以包括附接到偏转传感器的可植入传感器支撑构件，所述传感器支撑构件构造成促进偏转传感器与靠近第二容器的第一容器的部分处的第一血管壁之间的接触，其中 第一容器壁的部分与第二容器相邻，使得第二容器的壁偏转使第一容器壁的部分偏转。 测量血管参数的方法可以包括从静脉内的传感器产生偏转信号，所述偏转信号指示静脉的静脉壁偏转，以及使用偏转信号确定与接触静脉的血管相关联的参数值 。
-
公开(公告)号：US08086309B2
公开(公告)日：2011-12-27
申请号：US12767604
申请日：2010-04-26
CPC分类号： A61N1/3702 , A61B5/0006 , A61B5/02028 , A61B5/076 , A61B5/14539 , A61B5/14546 , A61B5/4869 , A61B2562/02 , A61N1/05 , A61N1/36521 , A61N1/36557 , G01N13/04
摘要： Embodiments of the invention are related to monitoring devices and methods with osmometric sensors, amongst other things. In an embodiment, an implantable heart failure monitoring system includes an implantable osmometric sensor configured to generate a signal corresponding to osmotic strength of a bodily fluid. The osmometric sensor includes a rigid wall member defining an enclosed volume resisting deformation, the rigid wall member comprising a semi-permeable membrane. The sensor also includes a signaling element comprising a first side, a second side, and a plurality of dimples configured to resist deformation until a threshold differential exists between the first and second sides. Other aspects and embodiments are provided herein.
摘要翻译： 本发明的实施例涉及到具有渗压传感器的监测装置和方法以及其它方面。 在一个实施例中，可植入心力衰竭监测系统包括被配置为产生对应于体液渗透强度的信号的可植入渗透传感器。 渗透传感器包括限定封闭体积的抗变形的刚性壁构件，刚性壁构件包括半透膜。 该传感器还包括信令元件，其包括第一侧面，第二侧面和多个凹坑，其被配置为抵抗变形，直到在第一和第二面之间存在阈值差异。 本文提供了其它方面和实施例。
-
-
-
-
-
-
-
-
-
搜索结果
17 条记录 (耗时 0.019 秒)
